NCT02159053 · Interventional trial
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
Overall registry status Completed
Phase 3
Conditions Spondylitis, Ankylosing
Delaware Valley sites
- Novartis Investigative Site · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory